The Valley Desk

ArticleCureusPublished

Evaluating the Usage of Janus Kinase Inhibitors in Rheumatology and Its Impact on Cardiovascular Risk

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Capital Health. Affiliation source

Institution
Capital Health

Publication record

Type
Article
Venue
Cureus
Published
Subject terms
Rheumatoid arthritis; Psoriatic Arthritis; Tofacitinib; Jak 2 Kinase Inhibitor; Lipid Worsening
PubMed ID
39192918
PubMed Central ID
PMC11349240
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal